Global MHC Tetramers Market Growth (Status and Outlook) 2025-2031

The global MHC Tetramers market size is predicted to grow from US$ 12.7 million in 2025 to US$ 20.6 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.

In 2023, North America accounted for the largest sales share of the MHC tetramer market. The region is characterized by a large number of pharmaceutical R&D service providers. Meanwhile, Asia Pacific is expected to witness the highest CAGR during the forecast period.

The major global companies of Major Histocompatibility Complex (MHC) Tetramer include:

• MBL Life Science
• ProImmune
• BioLegend
• KACTUS
• Creative Biolabs
• immunAware
• HELIXGEN
• ACROBiosystems

In terms of application, the continued research demand for cancer immunotherapy and adoptive T cell therapy and immune responses to emerging and re-emerging viral infectious diseases such as COVID-19, HIV and influenza is the main reason driving the MHC tetramer market. In 2023, MHC tetramers for cancer research accounted for approximately 48.00% of the market.

Currently, the MHC tetramer market mainly consists of two types: MHC-I and MHC-II. MHC-I is mainly used for research on cancer, viruses, bacteria, etc., and MHC-II is mainly used for research on viruses, bacteria, allergens, etc. In 2023, the sales of MHC-I and MHC-II will be US$6.63 million and US$4.29 million, respectively.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for MHC Tetramers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.